Pharma Mar
€71.40Change from previous close: +0.92%Absolute change: +€0.65
At a glance
- Revenue growth
- +26.61%
- 2025 vs 2024
- Net income growth
- +187.03%
- 2025 vs 2024
- Net margin
- 33.9%
- 2024: 14.9%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 49.6 | 42.9 | 90.5 | 35.7 | 56.4 | 38.9 | 48.4 | 45.7 | 42.9 | 38.0 | 40.5 | 37.5 |
| Cost of revenue | 4.7 | 3.7 | 3.8 | 2.3 | 2.8 | 3.4 | 1.3 | 2.0 | 3.1 | 1.8 | 2.5 | 3.1 |
| Gross profit | 44.9 | 39.2 | 86.7 | 33.4 | 53.6 | 35.5 | 47.0 | 43.6 | 39.8 | 36.2 | 38.1 | 34.3 |
| Selling, general and administrative | 17.1 | 15.3 | 17.3 | 6.6 | 14.7 | 13.7 | 13.2 | 10.7 | 19.4 | 11.0 | 11.4 | 8.9 |
| Research and development | 26.4 | 20.9 | 25.6 | 22.1 | 26.2 | 21.3 | 27.5 | 24.7 | 24.1 | 27.2 | 29.0 | 23.7 |
| Operating income | -1.4 | 0.6 | 43.6 | -4.0 | 24.2 | -3.1 | 4.9 | 5.5 | 0.4 | -4.3 | -5.1 | -0.2 |
| EBIT | -1.4 | 0.6 | 43.6 | -4.0 | 24.2 | -3.1 | 4.9 | 5.5 | 0.4 | -4.3 | -5.1 | -0.2 |
| EBITDA | 0.7 | 2.7 | 45.6 | -1.9 | 26.1 | -1.1 | 7.0 | 7.0 | 1.9 | -2.8 | -4.4 | 1.3 |
| Interest expense | — | — | 0.7 | 0.1 | 0.8 | 0.8 | 2.5 | 1.6 | — | — | 2.4 | — |
| Pre-tax income | -1.0 | 1.6 | 44.3 | -4.1 | 23.4 | -3.9 | 9.5 | 3.9 | 1.3 | -2.8 | -6.5 | 1.6 |
| Income tax | -0.0 | 0.1 | -15.4 | 0.0 | -0.0 | 0.0 | -9.1 | -0.0 | 0.1 | -5.1 | 0.3 | 0.0 |
| Net income | -1.0 | 1.5 | 59.7 | -4.1 | 23.4 | -3.9 | 18.7 | 3.9 | 1.2 | 2.3 | -6.8 | 1.5 |
| Net income to common shareholders | -1.0 | 1.5 | 59.7 | -4.1 | 23.4 | -3.9 | 18.7 | 3.9 | 1.2 | 2.3 | -6.8 | 1.5 |
| Basic EPS | -0.06 | 0.09 | 3.44 | — | 1.34 | -0.23 | 1.06 | — | 0.07 | — | -0.39 | — |
| Diluted EPS | -0.06 | 0.09 | 3.44 | — | 1.34 | -0.23 | 1.06 | — | 0.07 | — | -0.39 | — |
| Average shares (basic) | 17.3 | 17.3 | 17.4 | — | 17.4 | 17.3 | 17.6 | — | 17.5 | — | 17.6 | — |
| Average shares (diluted) | 17.3 | 17.3 | 17.4 | — | 17.4 | 17.3 | 17.6 | — | 17.5 | — | 17.6 | — |
| Dividend per share | — | — | 1.00 | — | — | — | 0.80 | — | — | — | 0.65 | — |